186 related articles for article (PubMed ID: 9272330)
21. Pertussis in a rural area of Kenya: epidemiology and a preliminary report on a vaccine trial.
Mahieu JM; Muller AS; Voorhoeve AM; Dikken H
Bull World Health Organ; 1978; 56(5):773-80. PubMed ID: 310719
[TBL] [Abstract][Full Text] [Related]
22. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
23. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
24. [Can we control pertussis better? II. Old and new vaccines against pertussis].
Gałazka A
Przegl Epidemiol; 1997; 51(3):285-95. PubMed ID: 9411499
[TBL] [Abstract][Full Text] [Related]
25. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
Olin P
Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
[TBL] [Abstract][Full Text] [Related]
26. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
27. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
White JM; Fairley CK; Owen D; Matthews RC; Miller E
Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
[TBL] [Abstract][Full Text] [Related]
28. Pertussis--United States, January 1992-June 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(28):525-9. PubMed ID: 7603428
[TBL] [Abstract][Full Text] [Related]
29. Potential impact of acceleration of the pertussis vaccine primary series for infants.
Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA
Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982
[TBL] [Abstract][Full Text] [Related]
30. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
[TBL] [Abstract][Full Text] [Related]
31. [Pertussis in 1997].
Tomaszunas-Błaszczyk J
Przegl Epidemiol; 1999; 53(1-2):23-32. PubMed ID: 10402846
[TBL] [Abstract][Full Text] [Related]
32. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
33. [Pertussis: a reemerging infection?].
Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
[TBL] [Abstract][Full Text] [Related]
34. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
36. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Uberall MA; Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; Laussucq S; Eckhardt T
Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
[TBL] [Abstract][Full Text] [Related]
37. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.
Pichichero ME; DeTora LM; Johnson DR
Expert Rev Vaccines; 2006 Apr; 5(2):175-87. PubMed ID: 16608418
[TBL] [Abstract][Full Text] [Related]
38. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
[TBL] [Abstract][Full Text] [Related]
39. Adolescent and adult pertussis: disease burden and prevention.
Edwards K; Freeman DM
Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
[TBL] [Abstract][Full Text] [Related]
40. [Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis].
Lutyńska A; Wiatrzyk A; Mosiej E; Zawadka M
Przegl Epidemiol; 2011; 65(1):45-50. PubMed ID: 21735835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
